Globus Medical

GMED · NYSE

$78.96+$3.31 (+4.38%)TodayMarket closed ·
Prev close $75.65

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The firm offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. The company separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.

Employees
6,000
Headquarters
Audubon, Pennsylvania
Listed
Mar 8, 2012
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Globus Medical executives
NameTitleSince
David Paul—2017
Keith Pfeil——
Kyle Kline——
Kelly Huller——
David Davidar—2003
John Deford——
Robert Douglas——
Daniel Lemaitre——
Leslie Norwalk——
Ann Rhoads——
James Tobin——
Daniel Wolterman——
Stephen Zarrilli——
Brian Kearns—2022

Revenue by product and region

Fiscal year ended Dec 31, 2025: $2.94B total revenue

By product

  • Musculoskeletal Solutions$2.80B95.2%
  • Enabling Technologies$141.01M4.8%

By region

  • United States$2.37B80.6%
  • International$571.34M19.4%

Similar companies

Companies in the same industry as Globus Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.